Bos Jl
Impact in
- Dermatology top 10%
- Skin Protection and Aging
-
- Acute Myeloid Leukemia Research
Papers in
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Maikel P. PeppelenboschW. KruijerLA SmetsHans van DamR SläterSjoerd RodenhuisH. BehrendtM. van ‘t Veer
- Journals
- Blood (4 papers)PubMed (8 papers)Arthritis Research (1 paper)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Bos Jl
13 papers receiving 374 citations
Peers
Comparison fields: 5 of 58
- Dermatology 47
- Hematology 51
- Oncology 118
- Molecular Biology 256
- Cancer Research 53
Countries citing papers authored by Bos Jl
This map shows the geographic impact of Bos Jl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bos Jl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bos Jl more than expected).
Fields of papers citing papers by Bos Jl
This network shows the impact of papers produced by Bos Jl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bos Jl. The network helps show where Bos Jl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bos Jl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 4 | |
| 2 | UV activation of receptor tyrosine kinase activity. | 1995 | 137 |
| 3 | Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling. | 1993 | 15 |
| 4 | Association of a tyrosine kinase activity with GAP complexes in v-src transformed fibroblasts. | 1992 | 13 |
| 5 | 1992 | 2 | |
| 6 | Co-regulated expression of junB and MHC class I genes in adenovirus-transformed cells. | 1991 | 9 |
| 7 | The repression of the growth factor-inducible genes JE, c-myc and stromelysin by adenovirus E1A is mediated by conserved region 1. | 1989 | 41 |
| 8 | Activated ras genes in human seminoma: evidence for tumor heterogeneity. | 1989 | 43 |
| 9 | Activation of N-ras induced by ultraviolet irradiation in vitro. | 1988 | 41 |
| 10 | Ras oncogenes in hematopoietic malignancies. | 1988 | 19 |
| 11 | 1987 | 20 | |
| 12 | 1986 | 4 | |
| 13 | 1986 | 42 |
About Bos Jl
Bos Jl is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Biotechnology, Oncology and Genetics, having authored 13 papers that have together received 390 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Virus-based gene therapy research (2 papers), Acute Myeloid Leukemia Research (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Cancer-related Molecular Pathways (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Dermatology (47 citations), Hematology (51 citations), Oncology (118 citations), Molecular Biology (256 citations) and Cancer Research (53 citations). Bos Jl has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Maikel P. Peppelenbosch, W. Kruijer, LA Smets, Hans van Dam, R Släter, Sjoerd Rodenhuis, H. Behrendt, M. van ‘t Veer, Rienk Offringa and W. Keijzer. Their work appears in journals such as Blood, PubMed and Arthritis Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.